Privia Health Group, Inc. (PRVA) - Q1 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2025. Privia Health Group, Inc. is a technology-driven, national physician-enablement company operating in 15 markets across the United States. The company organizes physicians into Medical Groups, providing management services and facilitating value-based care (VBC) arrangements. As of March 31, 2025, the company had 4,871 Implemented Providers and 1.27 million Attributed Lives.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Revenue | $480.1 million | $415.2 million |
| Operating Income | $5.2 million | $0.8 million |
| Net Income (GAAP) | $6.0 million | $3.1 million |
| Net Income Attributable to Privia | $4.2 million | $3.0 million |
| Adjusted EBITDA (Non-GAAP) | $26.9 million | $19.9 million |
| Cash and Cash Equivalents | $469.3 million | $351.1 million |
| Debt Outstanding | $0 | $0 |
Liquidity: The company holds $469.3 million in cash and cash equivalents. It maintains a $125 million senior secured revolving credit facility with no outstanding borrowings as of March 31, 2025.
Margins: Operating margin improved to 1.1% from 0.2% year-over-year. Adjusted EBITDA margin increased to 25.6% from 21.0%.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 15.6% to $480.1 million, driven by a 13.4% increase in Fee-for-Service (FFS) patient care revenue and a 37.8% surge in Capitated revenue.
- Profitability: Operating income grew 534% to $5.2 million, and Net Income attributable to Privia increased 41.4% to $4.2 million.
- Expense Trends: Provider expenses rose 17.0% to $374.8 million, tracking with revenue growth. Stock-based compensation increased significantly to $17.8 million (up from $11.9 million), impacting operating expenses.
- Cash Flow: Net cash used in operating activities was $24.1 million, an improvement from $33.1 million used in Q1 2024. This was primarily due to higher net income, partially offset by a $72.5 million increase in accounts receivable.
Guidance, Outlook, and Risks
Management Commentary: Management attributes growth to organic expansion, the addition of new providers, and the entry into the Indiana market in late 2024. The company continues to invest in sales, marketing, and technology to support provider onboarding and VBC transitions.
Recent Developments: In April 2025 (subsequent to the reporting period), Privia announced entry into the Arizona market via a partnership with a multi-specialty practice, involving a cash payment of approximately $95 million.
Risks and Contingencies:
- Regulatory Environment: The company operates in a heavily regulated industry; changes in healthcare laws or reimbursement rates could materially impact financial results.
- Concentration Risk: Three major payers accounted for 59% of total revenue in Q1 2025. Payer A alone represented 27% of revenue and 48% of accounts receivable.
- Technology Dependence: Operations rely heavily on third-party vendors, specifically athenahealth for electronic medical records (EMR).
- Provider Retention: While retention is historically high (96%), competition for providers remains intense.
Investor Verification Checklist
- Accounts Receivable Growth: Verify the sustainability of the $72.5 million increase in accounts receivable and its impact on future cash conversion.
- Arizona Expansion: Assess the financial impact and integration timeline of the $95 million Arizona market entry announced in April 2025.
- Stock-Based Compensation: Monitor the trajectory of stock-based compensation, which rose 49% year-over-year, and its effect on future GAAP profitability.
- Payer Concentration: Evaluate the risk associated with reliance on the top three payers, which collectively generate nearly 60% of revenue.
- Capitated Revenue Quality: Review the margin profile and risk exposure associated with the 37.8% growth in "at-risk" capitated revenue.